Quantcast

BioSpain 2010 to Showcase International Biotechnology Sector

August 6, 2010

MADRID, August 6, 2010 /PRNewswire/ — The Spanish Bioindustry
Association (ASEBIO), in collaboration with the Navarre Society of
Development (SODENA), and the government of Navarre, will host BioSpain 2010
(http://www.biospain.org), the biennial international gathering of experts in
the biotechnology sector, in Pamplona from September 29th to October 1st.
BioSpain 2010 is honoured to welcome three lecturers of international
prestige: Mr. Carlos Cordon-Cardo, Vice-Chair of Pathology & Professor,
Columbia University; Mr. Larry Fritz, President & CEO, Covella
Pharmaceuticals Inc. and Life Science Venture Partner, Westfield Capital
Management Company LP; and Mr. Conny Bogentoft, CEO Karolinska Development AB.

Internationalization will be the highlight of BioSpain this year – over
160 companies have already confirmed their participation in the trade
exhibition area, a 33% increase on BioSpain 2008.

BioSpain 2010 will feature an extensive program of breakout sessions
addressing the most relevant topics in the current biotech scenario,
including:

    - Bioenergy
    - Orphan Drugs & Rare Diseases
    - Alzheimer's and other neurodegenerative diseases: "What is the
      Spanish industry doing to develop new drugs?"
    - Protein Production & Biosimilars
    - Bioinformatics solutions for genomics: from sequences to
      Biotechnology and Biomedicine
    - Alternative Equity Market for Growth Companies
    - Venture Capital
    - Biotech's Next Big Thing?
    - Joint Technology Cooperation Projects between Spain and other
      countries: Eureka & Canadeka
    - International Technology Commercialization: The Challenges of
      US-European Public-Private Partnerships.

As on previous occasions, BioSpain 2010 will also host the scientific
conference organised by the Spanish Society of Biotechnology (SEBIOT), Biotec
2010.

An international round-table called “Opportunities and Challenges in
Global Biomarkets,” has also been confirmed. Its main aim is to discuss the
present state of the biotechnological industry, its development, and its
future prospects.

One of the most attractive aspects of BioSpain 2010 is the opportunity
for networking, with over 1,200 delegates from 650 companies & institutions
expected to attend.

Furthermore, the investors’ forum seeks to find new financing sources for
future entrepreneurial projects. 30 companies will present their business
plan to an audience of experts and investors, including representatives of
Merck & Co, Bay City Capital, La Caixa, Ysios Capital Partners,
GlaxoSmithKline Pharmaceuticals, Forbion Capital Partners, Suanfarma Biotech,
McKinsey & Company, and PharmaVentures.

Official sponsors of BioSpain 2010 include Caja de Navarra, The Zeltia
Group, Genoma Espana, AB Biotics, Genetrix, Merck, and ICEX.

    For more information:
    Lucia Cecilia Mercado
    Communication Manager at ASEBIO
    Tel. +34-91-210-93-74
    Mobile: +34-663-117-293
    lcecilia@asebio.com

    Berbes Asociados
    Tel. +34-91-563-23-00
    Maribel Otero/Jorge Sanchez
    maribelotero@berbes.com
    jorgesanchez@berbes.com

SOURCE ASEBIO


Source: newswire



comments powered by Disqus